7917 Stock Overview
Provides packaging materials, medical/pharmaceutical packaging materials, and materials for the functional fields in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
ZACROS Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥4,310.00 |
| 52 Week High | JP¥4,635.00 |
| 52 Week Low | JP¥3,580.00 |
| Beta | 0.56 |
| 1 Month Change | 4.61% |
| 3 Month Change | -1.49% |
| 1 Year Change | 14.02% |
| 3 Year Change | 3.73% |
| 5 Year Change | 19.89% |
| Change since IPO | 110.71% |
Recent News & Updates
Shareholder Returns
| 7917 | JP Chemicals | JP Market | |
|---|---|---|---|
| 7D | 1.4% | 1.7% | 2.1% |
| 1Y | 14.0% | 1.8% | 15.6% |
Return vs Industry: 7917 exceeded the JP Chemicals industry which returned 1.8% over the past year.
Return vs Market: 7917 underperformed the JP Market which returned 15.6% over the past year.
Price Volatility
| 7917 volatility | |
|---|---|
| 7917 Average Weekly Movement | 3.0% |
| Chemicals Industry Average Movement | 3.3% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in JP Market | 7.2% |
| 10% least volatile stocks in JP Market | 1.8% |
Stable Share Price: 7917 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 7917's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1914 | 2,664 | Taku Shimoda | www.zacros.co.jp |
ZACROS Corporation provides packaging materials, medical/pharmaceutical packaging materials, and materials for the functional fields in Japan and internationally. It operates through four segments: Wellness Business, Environmental Solutions Business, Electronic Materials Business, and Industrial Infrastructure Business. The company offers wellness products, including BioPhas, a customized service that is used in single-use products for biopharmaceuticals manufacturing; MediTect IV Bag, an infusion bags; and Total Thrombus formation Analysis System, a flow chamber system.
ZACROS Corporation Fundamentals Summary
| 7917 fundamental statistics | |
|---|---|
| Market cap | JP¥80.18b |
| Earnings (TTM) | JP¥4.70b |
| Revenue (TTM) | JP¥145.69b |
17.1x
P/E Ratio0.6x
P/S RatioIs 7917 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7917 income statement (TTM) | |
|---|---|
| Revenue | JP¥145.69b |
| Cost of Revenue | JP¥112.71b |
| Gross Profit | JP¥32.98b |
| Other Expenses | JP¥28.28b |
| Earnings | JP¥4.70b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 06, 2025
| Earnings per share (EPS) | 252.71 |
| Gross Margin | 22.64% |
| Net Profit Margin | 3.23% |
| Debt/Equity Ratio | 1.3% |
How did 7917 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield38%
Payout RatioDoes 7917 pay a reliable dividends?
See 7917 dividend history and benchmarks| ZACROS dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 23 2025 |
| Days until Ex dividend | 85 days |
| Days until Dividend pay date | 172 days |
Does 7917 pay a reliable dividends?
See 7917 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 15:15 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ZACROS Corporation is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mitsuharu Watanabe | Daiwa Securities Co. Ltd. |
| Katsuhiko Ishibashi | Ichiyoshi Research Institute Inc. |
| Shigekazu Ishida | Marusan Securities Co. Ltd. |